Chemodex

p-Coumaric acid

CHF 41.00
In stock
CDX-C0400-G01010 gCHF 41.00
CDX-C0400-G02525 gCHF 68.00
More Information
Product Details
Synonyms para-Coumaric Acid; trans-p-Coumaric Acid; trans-4-Hydroxycinnamic acid; (E)-3-(4-Hydroxyphenyl)prop-2-enoic acid
Product Type Chemical
Properties
Formula

C9H8O3

MW 164.16
CAS 501-98-4
RTECS GD9095000
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in ethanol (30 mg/ml), DMSO (15mg/ml) or DMF (20mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key NGSWKAQJJWESNS-ZZXKWVIFSA-N
Smiles OC1=CC=C(/C=C/C(O)=O)C=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

p-Coumaric acid is mainly a plant metabolite which exhibits antioxidant, antimicrobial, antitumor, antiangiogenic, antidiabetic, antihyperlipidemic, neuroprotective and anti-inflammatory properties. It shows bactericidal/quorum sensing activity by damaging bacterial cell membrane and by interacting with bacterial DNA. It prevents metabolic syndromes through the activation of brown adipose tissue (BAT), linked to UCP1 upregulation, with accelerated burning of fatty acids and glucose, leading to enhanced the energy expenditure and thermogenesis. Also used in proteomics, e.g. in western blot, p-coumaric is used as an enhancer in chemiluminescent substrates. Used in cosmetics as a skin-lightening compound, due to its antimelanogenic effects, based on its potent competitive inhibition of tyrosinase.

Product References

(1) C. Luceri, et al.; Br. J. Nutr. 97, 458 (2007) | (2) C. Haan & I. Behrmann; J. Immunol. Meth. 318, 11 (2007) | (3) S.F. Bodini, et al.; Lett. Appl. Microbiol. 49, 551 (2009) | (4) D. Dolores & C.Y. Cheng; Spermatogenesis 1, 121 (2011) | (5) D. Stojkovic, et al.; J. Sci. Food Agric. 93, 3205 (2013) | (6) S.J. Pragasam & M. Rasool; Inflamm. Res. 62, 489 (2013) | (7) S.J. Pragasam, et al.; Inflammation 36, 169 (2013) | (8) C.S. Kong, et al.; Phytother. Res. 27, 317 (2013) | (9) S. Shailasree, et al.; Mol. Neurobiol. 51, 119 (2015) | (10) V. Amalan, et al.; Biomed. Pharmacother. 84, 230 (2016) | (11) K. Pei, et al.; J. Sci. Food Agric. 96, 2952 (2016) (Review) | (12) A. Abdel-Moneim, et al.; Biomed. Pharmacother. 105, 1091 (2018) | (13) S.H. Sharma, et al.; Chem. Biol. Interact. 291, 16 (2018) | (14) R. Sakamula, et al.; Metab. Brain Dis. 33, 765 (2018) | (15) Y.C. Boo; Antioxidants 8, 275 (2019) (Review) | (16) X. Hu, et al.; Front. Oncol. 10, 558414 (2020) | (17) X. Han, et al.; FASEB J. 34, 7810 (2020) | (18) M.F. Abazari, et al.; Mini Rev. Med. Chem. (epub ahead of print) (2021) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.